Semisynthetic Macrolide Antibacterials Derived from Tylosin. Synthesis and Structure-Activity Relationships of Novel Desmycosin Analogues

Journal of Medicinal Chemistry

Volumn 47, Issue 2, 2004, Pages 411-431

  Mutak, Stjepan ^a   Maršić, Nataša ^a   Kramarić, Miroslava Dominis ^a   Pavlović, Dražen ^a  

^a PLIVA CROATIA LTD   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

10,11,12,13 TETRAHYDROTYLOSIN; 2,3 DIDEHYDRODESMYCOSIN; DESMYCOSIN; ERYTHROMYCIN; HYDROXYL GROUP; MACROLIDE; TILMICOSIN; TYLOSIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CATALYSIS; DRUG ACTIVITY; DRUG SYNTHESIS; ESTERIFICATION; MOUSE; NONHUMAN; OXIDATION; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; WITTIG REACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; MICE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION; TYLOSIN;

EID: 0346962946     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0308951     Document Type: Article

References (44)

1. Part of this material was presented at the 222nd National American Chemical Society Meeting, Chicago, IL, 2001, Medicinal Chemistry Division, Abstract MEDI 240.
2. Tylosin tartrate is sold commercially under the registered trademark Tylan by Elanco Products Co., a division of Eli Lilly. For pertinent biological information, see: McGuire, J. M.; Boniece, W. S.; Higgins, C. E.; Hoehn, M. M.; Stark, W. M.; Westhead, J.; Wolfe, R. N. Tylosin, a New Antibiotic. I. Microbiological Studies. Antibiot. Chemother. 1961, 11, 320-327.
3. Hamill, R. L.; Haney, M. E., Jr.; Stamper, M.; Wiley, P. F. Tylosin, a New Antibiotic. II. Isolation, Properties, and Preparation of Desmycosin, a Microbiologically Active Degradation Product. Antibiot. Chemother. 1961, 11, 328-334.
4. Macrolide Antibiotics. Chemistry, Biology, and Practice; Omura, S., Ed.; Academic Press: Orlando, FL, 1984.
5. Sartori, E.; Delaforge, M.; Mansuy, D. In Vitro Interaction of Rat Liver Cytochromes P-450 with Erythromycin, Oleandomycin and Erythralosamine Derivatives: Importance of Structural Factors. Biochem. Pharmacol. 1989, 38, 2061-2068.
6. Nakayama, I. In Macrolide Antibiotics. Chemistry, Biology, and Practice; Omura, S., Ed.; Academic Press: Orlando, FL, 1984; pp 261-298.
7. (a) Sakakibara, H.; Fujiwara, T.; Okegawa, O.; Honda, E.; Watanabe, S.; Matsuda, T. (Toyo Jozo) Deformyltylosin Derivatives. U.S. Patent 4345069, Aug 17, 1982.
8. (b) Kirst, H. A.; Toth, J. E.; Debono, M.; Willard, K. E.; Truedell, B. A.; Ott, J. L.; Counter, F. T.; Felty-Duckworth, A. M.; Pekarek, R. S. Synthesis and Evaluation of Tylosin-Related Macrolides modified at the Aldehyde Function: A New Series of Orally Effective Antibiotics. J. Med. Chem. 1988, 31, 1631-1641.
9. Debono, M.; Willard, K. E.; Kirst, H. A.; Wind, J. A.; Crouse, G. D.; Tao, E. V.; Vicenzi, J. T.; Counter, F. T.; Ott, J. L.; Ose, E. E.; Omura, S. Synthesis and Antimicrobial Evaluation of 20-Deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (Tilmicosin, EL-870) and Related Cyclic Amino Derivatives. J. Antibiot. 1989, 42, 1253-1267.
10. Kirst, H. A. Semisynthetic Derivatives of 16-Membered Macrolide Antibiotics. Prog. Med. Chem. 1994, 31, 265-295.
11. Kirst, H. A.; Leeds, J. P. (Eli Lilly) New Acyl Derivatives of 20-Modified Tylosin and Desmycosin Compounds. EP262903, Apr 6, 1988.
12. (a) Kageyama, S.; Tsuchiya, T.; Umezawa, S. Synthesis of 3-Deoxy-3,4-Didehydro Derivatives of 5-O-Mycaminosyltylonolide, 5-O-(4-Deoxymycaminosyl)tylonolide, and Desmycosin. J. Antibiot. 1993, 46, 1265-1278.
13. (b) Mallams, A. K.; Rossman, R. R. Novel 3-O-α-L-Cladinosyl Sixteen-membered Macrolide Anti-bacterials. J. Chem. Soc., Perkin Trans. 1 1989, 799-805.
14. (a) Naranda, A.; Šušković, B.; Kelnerić, Ž.; Dokić, S. Structure-Activity Relationship Among Polyhydro derivatives of Tylosin. J. Antibiot. 1994, 47, 581-587.
15. Naranda, A.; Kelnerić, Z.; Kolačny-Babić, L.; Dokič, S. 10,11,12,13-Tetrahydro Derivatives of Tylosin. II. Synthesis, Antibacterial Activity and Tissue Distribution of 4′ -Deoxy-10,11,12,13-tetra-hydrodesmycosin. J. Antibiot. 1995, 48, 248-253.
16. Naranda, A.; Šušković, B.; Dokić, S.; Lopotar, N. Preparation of Tylosin and 10,11,12,13-Tetrahydrotylosin Derivatives as Antibacterials. EP287082, Oct 19, 1988.
17. Fishman, A. G.; Mallams, A. K.; Puar, M. S.; Rossman, R. R.; Stephens, R. L. Novel Semisynthetic Oxo and Alkyl Macrolide Antibacterials and Related Derivatives. J. Chem. Soc., Perkin Trans. 1 1987, 1189-1209.
18. Creemer, L. C.; Toth, J. E.; Kirst, H. A. Synthesis and In vitro Antimicrobial Activity of 3-keto 16-Membered Macrolides Derived from Tylosin. J. Antibiot. 2002, 55, 427-436.
19. Naranda, A.; Lopotar, N.; Derek, M.; Pavlovič, D. 3-Deoxy Desmycosin Derivatives and Process of Their Preparation. PCT Int. Appl. WO0066602, Nov 9, 2000; 42 pp.
20. For reviews see the following (a) Flynn, D. L.; Devraj, R. V.; Parlow, J. J. Recent Advances in Polymer-Assisted Solution-Phase Chemical Library Synthesis and Purification. Curr. Opin. Drug Discovery Dev. 1998, 1, 41-50.
21. (b) Weller, H. N. Purification of Combinatorial Libraries. Mol. Diversity 1999, 4, 47-52.
22. (c) Ferritto, R.; Seneci, P. High Throughput Purification Methods in Combinatorial Solution Phase Synthesis. Drugs Future 1998, 23, 643-654.
23. (d) An, H.; Cook, P. D. Methodologies for Generating Solution-Phase Combinatorial Libraries. Chem. Rev. 2000, 100, 3311-3340.
24. (e) Weller, H. N.; Young, M. G.; Michalczyk, S. J.; Reitnauer, G. H.; Cooley, R. S.; Rahn, P. C.; Loyd, D. J.; Fiore, D.; Fischman, S. J. High Troughput Analysis and Purification in Support of Automated Parallel Synthesis. Mol. Diversity 1997, 3, 61-70.
25. Agouridas, C.; Denis, A.; Auger, J. M.; Benedetti, Y.; Bonnefoy, A.; Bretin, F.; Chantot, J. F.; Dussarat, A.; Fromentin, C.; D'Ambrieres, S. G.; Lachaud, S.; Laurin, P.; Martret, O. L.; Loyan, V.; Tessot, N. Synthesis and Antibacterial Activity of Ketolides (6-O-Methyl-3-oxoerythromycin Derivatives): A New Class of Antibacterials Highly Potent Against Macrolide-Resistant and Susceptible Respiratory Pathogens. J. Med. Chem. 1998, 41, 4080-4100.
26. Patt, S. L.; Shoolery, J. N. Attached Proton Test for Carbon-13 NMR. J. Magn. Reson. 1982, 46, 535-539.
27. Kirst, H. A. Expanding the Role of Macrolide Compounds as Therapeutic Agents. In Studies in Medicinal Chemistry; Iqbal Choudhary, M., Ed.; Harwood Academic Publishers: Amsterdam, The Netherlands, 1996; pp 1-47.
28. (a) Bryskier, A.; Denis, A. Ketolides: Novel Antibacterial Agents Designed to Overcome Resistance to Erythromycin A within Gram-positive Cocci. In Macrolide Antibiotics. (Milestones in Drug Therapy); Schönfeld, W., Kirst, H. A., Eds.; Birkhäuser Verlag: Basel, Switzerland, 2002; pp 97-140.
29. Silverstein, R. M.; Bassler, G. C.; Morrill, T. C. Spectrometric Identification of Organic Compounds, 4th ed.; John Wiley and Sons: New York, 1981.
30. Shuto, S.; Minakawa, N.; Nizuma, S.; Kim, H.-S.; Wataya, Y.; Matsuda, A. New Neplanocin Analogues. 12. Alternative Synthesis and Antimalarial Effect of (6′R)-6′-C-Methylneplanocin A, a Potent AdoHcy Hydrolase Inhibitor. J. Med. Chem. 2002, 45, 748-751.
31. Sakahibara, H.; Omura, S. Chemical Modification and Structure-Activity Relationship of Macrolides. In Macrolide Antibiotics. Chemistry, Biology, and Practice; Omura S., Ed.; Academic Press: Orlando, FL, 1984; pp 85-125.
32. Bothner-By, A. A.; Stephens, R. L.; Lee, J.; Warren, C. D.; Jeanloz, R. W. Structure Determination of a Tetrasaccharide: Transient Nuclear Overhauser Effects in the Rotating Frame. J. Am. Chem. Soc. 1984, 106, 811-813.
33. (a) Bax, A.; Davis, D. G. MLEV-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. J. Magn. Reson. 1985, 65, 355-360.
34. (b) Davis, D. G.; Bax, A. Simplification of Proton NMR Spectra by Selective Excitation of Experimental Subspectra. J. Am. Chem. Soc. 1985, 107, 7197-7198.
35. (c) Davis, D. G.; Bax, A. Separation of Chemical Exchange and Cross-Relaxation Effects in Two-Dimensional NMR Spectroscopy. J. Magn. Reson. 1985, 64, 533-535.
36. (a) Suwa, T.; Yoshida, H.; Fukushima, K.; Nagate, T. Comparative Pharmacokinetics of TE-031 and Erythromycin Stearate in Rats and Mice. Chemother. 1989, 36 (Suppl. 3), 198-204.
37. (b) Kohno, Y.; Yashida, H.; Suwa T.; Suga, T. Comparative Pharmacokinetics of Clarithromycin (TE-031), A New Macrolide Antibiotic, and Erythromycin in Rats. Antimicrob. Agents Chemother. 1989, 33, 751-756.
38. Bax, A.; Freeman, R. Investigation of Complex Networks of Spin-Spin Coupling by Two-Dimensional NMR. J. Magn. Reson. 1981, 44, 542-561.
39. (b) Bax, A.; Freeman, R. Long-Range Proton-Carbon-13 NMR Spin Coupling Constants. J. Am. Chem. Soc. 1982, 104, 1099-1100.
40. Bax, A.; Subramanian, S. Sensitivity-Enhanced Two-Dimensional Heteronuclear Shift Correlation NMR Spectroscopy. J. Magn. Reson. 1986, 67, 565-569.
41. Sarkar, S. K.; Bax, A. A Simple and Sensitive One-Dimensional NMR Technique for Correlation of Proton and Carbon Chemical Shifts. J. Magn. Reson. 1985, 62, 109-112.
42. 13C Couplings. J. Magn. Reson. 1984, 57, 314-318.
43. NCCLS Document M7-A5, 20. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 5th ed., Jan 2000.
44. Tanaka, A.; Watanabe, A.; Tsuchiya, T.; Umezawa, S.; Umezawa, H. Synthesis of 4′-Deoxydemycarosyl Tylosin and Its Analogues. J. Antibiot. 1981, 1381-1384.